Eos Energy stock falls after Fuzzy Panda issues short report
Investing.com - TD Cowen has reiterated its Buy rating and $150.00 price target on Agilent (NYSE:A), currently trading at $122.27, following the company’s quarterly results that showed strong revenue growth despite margin pressure. According to InvestingPro data, analyst targets range from $120 to $165, with the company maintaining a GOOD financial health score.
The laboratory equipment maker, with a market capitalization of $34.7 billion, reported organic growth of 6.1% in its fiscal third quarter, significantly outpacing the consensus expectation of 3.6%, according to TD Cowen analyst Dan Brennan.
The firm noted that Agilent’s growth was "broad based" across its business segments, with the company forecasting continued strong performance through the fiscal fourth quarter and into the first quarter of fiscal 2026.
Despite the revenue beat, Agilent’s margins missed analyst expectations by approximately 150 basis points, which TD Cowen attributed to tariffs, foreign exchange impacts, and ongoing investments.
The research firm maintained its positive outlook on Agilent, citing expectations for "improving top line & margin expansion ahead" despite the current margin challenges.
In other recent news, Agilent Technologies reported its third-quarter earnings for 2025, meeting expectations with an earnings per share (EPS) of $1.37. The company’s revenue for the quarter exceeded forecasts, coming in at $1.74 billion against the anticipated $1.67 billion. This marks a significant development for Agilent as it demonstrates strong performance in its financial results. Additionally, Bernstein SocGen Group reiterated its Market Perform rating for Agilent, maintaining a price target of $125.00. Analyst Eve Burstein highlighted Agilent’s fifth consecutive quarter of sequential core revenue acceleration, indicating widespread improvement across its business segments. These recent developments reflect a positive trajectory for Agilent, with strong organic growth signaling continued market recovery.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.